Encompass Health (EHC) closed at $140.83 on November 12, 2026, down 1.0% from the previous close, on volume of 602,937 shares (30-day average 1,107,100).
Data as of November 12, 2026.
12-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 29, 2026 | Put Spread | 20-Nov-26120 : 130 P | 1,500 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
PRNewswire (Fri, 6-Nov 7:30 AM ET)
Encompass Health reports results for third quarter 2026
PRNewswire (Wed, 28-Oct 4:20 PM ET)
PRNewswire (Mon, 26-Oct 4:30 PM ET)
Encompass Health Rehabilitation Hospital of Westover Hills now open in Texas
PRNewswire (Thu, 22-Oct 4:30 PM ET)
Encompass Health declares dividend on common stock
PRNewswire (Thu, 22-Oct 8:53 AM ET)
PRNewswire (Mon, 19-Oct 4:30 PM ET)
Encompass Health Rehabilitation Hospital of Bangor now open in Maine
PRNewswire (Tue, 6-Oct 4:31 PM ET)
Encompass Health announces date of 2026 third-quarter earnings call
PRNewswire (Thu, 1-Oct 4:30 PM ET)
PRNewswire (Thu, 24-Sep 4:31 PM ET)
Encompass Health Rehabilitation Hospital of Lower Providence now open in Pennsylvania
PRNewswire (Tue, 15-Sep 4:30 PM ET)
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Encompass Health trades on the NYSE stock market under the symbol EHC.
As of November 12, 2026, EHC stock price declined to $140.83 with 602,937 million shares trading.
EHC has a beta of 0.47, meaning it tends to be less sensitive to market movements. EHC has a correlation of 0.04 to the broad based SPY ETF.
EHC has a market cap of $13.84 billion. This is considered a Large Cap stock.
Last quarter Encompass Health reported $2 billion in Revenue and $1.52 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.16.
In the last 3 years, EHC traded as high as $143.90 and as low as $63.02.
The top ETF exchange traded funds that EHC belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
EHC has outperformed the market in the last year with a price return of +22.5% while the SPY ETF gained +12.0%. EHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +12.5% and +15.3%, respectively, while the SPY returned -1.5% and -2.0%, respectively.
EHC support price is $139.22 and resistance is $145.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EHC shares will trade within this expected range on the day.
